SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK

Supernus to Provide Preliminary Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on February 28, 2022

22 2 2022 15:30:00 提供 Nasdaq GlobeNewswire

Supernus Receives Notice Assigning Early October 2022 PDUFA for SPN-830 Apomorphine Infusion Device NDA

22 2 2022 07:00:01 提供 Nasdaq GlobeNewswire

Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device

08 12 2021 07:30:00 提供 Nasdaq GlobeNewswire

Supernus Pharmaceuticals Targeted in Ransomware Incident

24 11 2021 17:58:37 提供 Nasdaq GlobeNewswire

Supernus Pharmaceuticals Completes Acquisition of Adamas Pharmaceuticals

24 11 2021 08:12:51 提供 Nasdaq GlobeNewswire

Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Adamas Pharmaceuticals Tender Offer

23 11 2021 07:00:00 提供 Nasdaq GlobeNewswire

Supernus to Participate in Annual Piper Sandler Healthcare Conference

18 11 2021 07:00:02 提供 Nasdaq GlobeNewswire

Supernus to Participate in Upcoming November Investor Conferences

10 11 2021 15:05:03 提供 Nasdaq GlobeNewswire

Supernus Announces Third Quarter 2021 Financial Results

03 11 2021 15:01:01 提供 Nasdaq GlobeNewswire

Supernus to Announce Third Quarter 2021 Financial Results and Host Conference Call on November 3, 2021

27 10 2021 16:42:55 提供 Nasdaq GlobeNewswire

Holly Robinson Peete Partners with Supernus to Raise Awareness During ADHD Awareness Month

20 10 2021 07:00:02 提供 Nasdaq GlobeNewswire

Supernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product Portfolio

11 10 2021 05:30:00 提供 Nasdaq GlobeNewswire

Supernus Announces Qelbree™ sNDA for Adult Indication Accepted for Review by FDA

02 9 2021 17:45:00 提供 Nasdaq GlobeNewswire

Supernus to Participate in Upcoming September Investor Conferences

02 9 2021 08:00:00 提供 Nasdaq GlobeNewswire

Supernus Announces Second Quarter 2021 Financial Results

04 8 2021 15:09:33 提供 Nasdaq GlobeNewswire

Supernus to Host Second Quarter 2021 Financial Results Conference Call

22 7 2021 15:37:21 提供 Nasdaq GlobeNewswire

Supernus to Present at Jefferies Virtual Healthcare Conference

25 5 2021 07:30:00 提供 Nasdaq GlobeNewswire

Qelbree™ (viloxazine extended-release capsules), a New Non-Controlled Substance, Now Available for the Treatment of ADHD in Pediatric Patients 6-17 Years of Age

24 5 2021 07:30:00 提供 Nasdaq GlobeNewswire

Supernus Announces First Quarter 2021 Financial Results

05 5 2021 15:01:00 提供 Nasdaq GlobeNewswire

Supernus Announces Paragraph IV ANDA Filing for XADAGO®

04 5 2021 19:49:10 提供 Nasdaq GlobeNewswire